We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

AM:EURONEXT PARISDassault Aviation SA Analysis

Data as of 2026-03-11 - not real-time

$22.98

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Antero Midstream trades near $23, well above its DCF‑derived fair value of $5.69, implying a ~9% downside from current levels. The stock sits atop its 20‑day ($22.08) and 50‑day ($19.81) SMAs, signaling a bullish price trend, yet the 14‑day RSI of 76 points to an overbought condition and the MACD histogram has turned negative, suggesting short‑term pressure. Free cash flow surged 30% YoY to $325 M for the year, supporting debt reduction and $48 M of share repurchases, while the recent $1.1 B acquisition of HG Midstream expands the asset base and is expected to lift adjusted EBITDA by 8% YoY. Dividend yield remains attractive at 3.98% but the payout ratio exceeds 100% (≈104.6%), raising questions about sustainability.
The company’s low beta (0.45) and moderate 30‑day volatility (≈20%) indicate limited market‑wide risk, but high leverage (debt‑to‑equity > 160) and sector‑specific regulatory exposure temper the outlook. Overall, the stock appears overvalued with strong cash generation and growth catalysts, but near‑term technical signals and dividend sustainability concerns warrant caution.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • RSI in overbought territory (76) and bearish MACD histogram
  • Current price exceeds DCF fair value by ~9%
  • Decreasing volume trend suggests limited upside momentum

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • 30% YoY free cash flow growth and debt reduction progress
  • Strategic HG Midstream acquisition expanding pipeline footprint
  • High dividend payout ratio (>100%) may pressure cash flow

Long Term

> 3 years
Cautious
Model confidence: 7/10

Key Factors

  • Elevated leverage (debt‑to‑equity >160) limits financial flexibility
  • Overvaluation relative to fundamentals and DCF
  • Potential regulatory headwinds in the midstream energy sector

Key Metrics & Analysis

Financial Health

Revenue Growth3.10%
Profit Margin32.81%
P/E Ratio26.7
ROE20.22%
ROA7.86%
Debt/Equity163.41
P/B Ratio5.5
Op. Cash Flow$932.5M
Free Cash Flow$362.1M
Industry P/E20.7

Technical Analysis

TrendBullish
RSI76.1
Support$19.93
Resistance$23.10
MA 20$22.08
MA 50$19.81
MA 200$18.55
MACDBearish
VolumeDecreasing
Fear & Greed Index75.41

Valuation

Fair Value$5.69
Target Price$20.86
Upside/Downside-9.22%
GradeOvervalued
TypeBlend
Dividend Yield3.98%

Risk Assessment

Beta0.45
Volatility20.09%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.